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Abstract The role of apoptosis in the persistence of hepa-
titis C virus (HCV) infection is controversial. Moreover,
conflicting data on the modulation of this process by HCV
proteins have been provided. We evaluated the susceptibility
of peripheral lymphocytes from patients with chronic hepa-
titis C to apoptosis both spontaneous and after incubation
with a chimeric Cucumber mosaic virus (CMV) carrying
180 copies of the synthetic R9 mimotope obtained from
more than 200 hypervariable region-1 sequences of HCV.
Resting T lymphocytes were found to be sensitized to apo-
ptosis as a result of chronic HCV infection. The plant virus-
derived vector R9-CMV displayed a strong pro-apoptotic
effect associated with activation of both caspase-8 and −9,
indicating the involvement of both extrinsic and intrinsic
apoptotic pathways. A parallel R9-CMV-mediated activation
of endoplasmic reticulum-stress was suggested by the signif-
icant induction of BiP/GRP78, GADD153 and caspase-12.
These data contribute to define the complex HCV/host inter-
action, and open new prospects for developing a plant-derived
antigen-presenting system to strengthen host defences against
persistent pathogens.
Keywords Apoptosis . HCV. cucumber mosaic virus .
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Introduction
The ability of hepatitis C virus (HCV) to persist indefinitely in
the infected host, together with the current unavailability of a
fully effective therapy and of a protective vaccine against this
virus, are the main reasons why HCV infection is imposing a
growing burden on health systems worldwide. The mecha-
nisms whereby this pathogen establishes persistent infection
remain elusive, but it is widely recognized that subversion of
host immune responses byHCVmight explain the high rate of
chronic infections. HCV clearance has, in fact, been correlated
with strong and persistent cytotoxic T lymphocyte (CTL)
responses directed against multiple HCV epitopes [1–3]. In
this context, a chimeric form of the plant virus Cucumber
mosaic virus (CMV), the so-called R9-CMV [4], genetically
engineered to express on its coat protein 180 copies of the
synthetic R9 mimotope obtained from more than 200 hyper-
variable region (HVR)-1 sequences of HCV [5], has been
demonstrated to induce a significant enhancement of HCV-
specific CTL activities [6, 7].
Modifications of cell apoptosis have been hypothesized to
affect HCV persistence and virus-related tissue damage as
well, even though it has still to be understood whether the
apoptotic process is linked to the clearance or the persistence
of HCV infection [8]. Although there is increasing evidence
suggesting that liver damage caused by viral infections (i.e.
HBV, HCV), autoimmune reactions, toxins and cholestasis is
mediated by inappropriate induction of cell apoptosis [9], it is
currently assumed that programmed cell death is an important
mechanism of host defence against intracellular pathogens
and tumorigenesis [10]. Cytotoxic T lymphocyte effectiveness
in destroying virus-infected cells or any other cell that poses a
threat to the integrity of the organism is strictly related to the
CTL ability to trigger the apoptotic process directly or through
the mediation of pro-apoptotic cytokines [11]. In this regard, a
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defective apoptosis has been implicated as a major determi-
nant in the development of hepatocellular carcinoma (HCC)
[12]. Moreover, the HCV ability to directly infect immune
cells, including peripheral lymphocytes and monocytes, might
affect their function and down-modulate apoptotic events,
thereby allowing virus chronic replication in target cells
[13]. However, the susceptibility of the peripheral immune
system to the apoptotic process in the course of chronic HCV
infection has not yet been studied in depth.
To date, there is still controversy as regards the apoptotic
effect of HCV, also because the genetic heterogeneity of the
virus makes it difficult to compare the apoptotic pathways
elicited by different HCV genotypes. The role of specific
HCV proteins in such a process also remains unclear. The
HCV core protein has been widely studied and in vitro it has
been shown either to inhibit or to enhance apoptosis induced
by several stimuli, depending on experimental conditions and
type of cells used [14–17]. Similarly, both anti- and pro-
apoptotic effects of HCV NS3, NS4A, NS5A and NS5B
proteins have been described [18–21] and few, conflicting data
are available on the HCV envelope protein-mediated modula-
tion of programmed cell death [22, 23].
The current study was designed to evaluate whether chron-
ic HCV infection affects the susceptibility of peripheral im-
mune cells to the spontaneous apoptosis process. In addition,
we used the plant-derived antigen (Ag)-presenting systemR9-
CMV to investigate the ability of HVR1-derived peptides to
modulate, in vitro, peripheral lymphocyte apoptosis. We
found that resting T lymphocytes isolated from patients with
chronic hepatitis C were sensitized to apoptosis and that the
R9 mimotope, expressed on the CMV surface, exerted a
strong pro-apoptotic effect on peripheral lymphocytes. Inter-
estingly, the chimeric virus R9-CMVinduced significant levels
of both active caspase-8 and −9, suggesting that both the
extrinsic and the intrinsic apoptotic pathway contributed to
the downstream activation of the R9-CMV-dependent apopto-
sis execution phase. At the same time, evidence of a R9-CMV-
dependent endoplasmic reticulum (ER)-stress activation,
closely related to cell apoptosis, was also gained, opening
new perspectives on the mechanisms underlying HCV-
induced apoptosis.
Materials and Methods
Construction of Chimeric Virus and Plant Infection
Two strains of CMV, namely CMV-D and CMV-S, were
propagated in Nicotiana tabacum cv. Xanthi and purified as
described by Lot et al. [24]. A pseudorecombinant CMV-D/
S was made, derived from the RNA 3 component of the
CMV-S strain carrying the coat protein (CP) gene and the
RNA 1,2 component of the CMV-D strain. The CMV-S CP
gene (AF063610) used in this study was obtained from full–
length cDNA copies of CMV-S genomic RNA 3 (pCMV3S)
of 2078 nt (the gift of Marie Tousignant, Agricultural Re-
search Service, U.S.D.A., Beltsville, MD 20705, USA). The
R9 mimotope nucleotide sequence was inserted in position
529 of the CP gene, as described by Natilla et al. [4], and the
resultant plasmid served as template for in vitro generation
of the corresponding CMV-S chimeric RNA 3.
One μg of DNA template was then used in a 20 μl
volume reaction for synthesizing capped transcripts using
the T7 mMessage mMachineTM Kit (Ambion Europe LTD,
Cambridgeshire, U.K.). Before transcription, the template
was linearized with Sma I. The in vitro CMV-S RNA 3
transcript was then supplemented with the other two CMV
genomic RNAs (RNA1,2/RNA3 1:2) deriving from CMV-D,
to obtain the chimeric R9-CMV. A final RNA concentration of
0.5 μg/μl in 50mMpotassium phosphate, pH 7.0, was used to
inoculate Nicotiana tabacum cv. Xanthi plants at the four-leaf
stage. To verify the R9-CMVability to spread systemically in
the host, as well as to demonstrate that the R9 mimotope was
exhibited in the planned exposed position, tissues were
analyzed by RT-PCR, Western blot, ELISA and electron
microscopy 10 days after inoculation, as previously de-
scribed [4]. R9-CMV particles were purified and quantified
by measuring the optical density of the virus suspension at
260 nm. Virus extraction yielded an average of 10mg/100 g of
fresh tissue.
CMV-D/S purified particles were used as controls in all
the experiments.
Patients
Forty untreated patients with chronic HCV infection (23 males
and 17 females; mean age 51 years, range 27–65 years), ad-
mitted to the Department of Internal Medicine, Bari University
Hospital, were enrolled in the study after giving informed
consent. All patients were positive for HCV-RNA by polymer-
ase chain reaction (PCR), had had abnormal alanine amino-
transferase (ALT) serum levels for at least 6 months before
inclusion in the study and had histopathological confirmation
of chronic hepatitis. Exclusion criteria included alcoholism,
use of hepatotoxic drugs, clinical and/or histological evidence
of autoimmune hepatitis, inherited metabolic disorders and co-
infection with other hepatotropic viruses (i.e., HBVand HDV).
The HCV genotype was determined by Inno-Lipa HCV II
(Innogenetics N.V., Ghent, Belgium), that allows genotyping
of the 6 major HCV types and their most common subtypes.
With this approach we found genotype 1b in 26 patients, 2a/2c
in 11 patients and 3a in 3 patients. However, no differences in
terms of apoptotic phenomena were observed among patients
with regard to their histopathological pattern or viral genotype.
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Twenty HCV negative healthy donors were included in
the study as controls.
Cell Cultures
PBMC were isolated from heparinized venous blood by Lym-
pholyte (Cedarlane Laboratories, Hornby, Ontario, Canada)
density gradient centrifugation. The cell suspensions recov-
ered at the interface were washed and resuspended in RPMI
1640 (Sigma Chemical Co., Milan, Italy) supplemented with
penicillin (200 IU/ml), streptomycin (100 μg/ml), L-
glutamine (2 mM) and 10% heat inactivated fetal calf serum
(FCS) (complete medium). The monocyte concentration in
PBMC suspensions was approximately 15%, as evaluated
by cytochemical (non-specific esterase) criteria.
PBMC (2×105 cells/well; 1×106 cells/mL) were incubat-
ed for 10 days at 37°C 5% CO2 in 96-well round-bottom
microtiter plates (Corning Costar, Milan, Italy) in the pres-
ence of medium alone (Not Stimulated cells—NS), synthet-
ic peptide R9 (10 μg/mL), R9-CMV (5 μg/mL), CMV-D/S
(5 μg/mL) or, where indicated, Thapsigargin (TG, 2 μM).
PBMC were recovered daily in pilot experiments, and
then after 48 h (specifically with reference to experiments in
which TG was used), 3 days (T3) or 7 days (T7) of culture,
to be analyzed for apoptotic events.
Where indicated, cell cultures were supplemented
with purified caspase-8 (Z-IETD-FMK) or caspase-9
(Z-LEHD-FMK) inhibitors (5 μM/well) (Alexis Bio-
chemicals; Vinci-Biochem, Florence, Italy), and cell apopto-
sis, as well as the activity of the inhibitor-free caspase, were
evaluated after 3 days of incubation. For Western blot analy-
sis, PBMC (5–8×106 cells/flask, 1×106 cells/mL) were cul-
tured for 48 and 72 h at 37°C 5% CO2 in 25 cm
2 flasks
(Corning Costar) in the presence of R9-CMV (5 μg/ml), TG
(2 μM) as stimulants, or medium alone.
All reagents were LPS-free, as assessed by the Limulus
amebocyte lysate assay (PBI International, Milan, Italy).
Cytofluorimetric Analysis of Cell Apoptosis
PBMC apoptosis was measured by flow cytometry using the
Annexin V-FITC/7-AAD kit (provided by Beckman Coulter
Inc., Miami, FL, USA), following the manufacturer’s instruc-
tions. Annexin V binds specifically to phosphatidylserine
(PS), a phospholipid usually located in the inner leaflet of
the plasma membrane that, in the early phase of apoptosis,
becomes exposed at the cell surface and acts as a specific
signal for recognition and removal of apoptotic cells by mac-
rophages. Instead, 7-AAD is a DNA specific viability dye
recognizing necrotic cells.
PBMC recovered from culture plates were washed with
cold phosphate-buffered saline (PBS) and resuspended in
0.5 mL of binding buffer (Hepes 10 mM, NaCl 140 mM,
CaCl2 2.5 mM pH 7.4) in 2 mL conical bottom tubes. Cell
suspensions were stained with Annexin V-FITC/7AAD at
saturating concentrations, [Phycoerythrin (PE)-Texas Red]
(ECD)-conjugated anti-CD3 and PE-labeled anti-CD19
monoclonal antibodies (mAbs) (all purchased from Beck-
man Coulter Inc.) on ice for 15 min in the dark. Then 400 μl
of ice-cold Binding Buffer were added, cell preparations
were analyzed within 30 min on a flow cytometer/cell sorter
COULTER Epics Elite (Beckman Coulter Inc.) equipped
with a 15 mm air-cooled, 488 nm argon-ion laser. Gating
on physical parameters (forward- and side-scatter) was used
to define lymphocytes and exclude cell debris and clumps.
In each experiment, 15000 events were analyzed.
Detection of Active Cellular Caspases by a Cytofluorimetric
Technique Based on a FLuorochrome Inhibitor of Caspases
(FLICA)
To study active cellular caspases, we used a method based
on cell permeable, non-cytotoxic and fluorochrome-labeled
inhibitors of caspases (FLuorochrome Inhibitors of CAspases
—FLICA) that, once inside the cell, bind covalently to the
respective active caspase, labeling it and inhibiting any further
enzymatic activity. The complex caspase-inhibitor is retained
within the cell, while any unbound reagent diffuses out of the
cell and is washed away, so that the fluorescent signal is a
direct measure of the number of active caspase enzymes
present in the cell at the time the reagent is added. In this
study, we used carboxyfluorescein (FAM)-labeled fluoro-
methyl ketone (FMK) peptide inhibitors of caspases emitting
a green fluorescence that can be analyzed by flow cytometry.
Aliquots of PBMC under different experimental condi-
tions (NS cells, cells treated with R9 peptide, R9-CMV or
CMV-D/S) were collected after 3 and 7 days of culture,
washed and incubated for 1 h in the dark at 37°C under 5%
CO2 in the presence of the Poly-Caspases FLICA reagent
(FAM-VAD-FMK), that irreversibly binds to many activated
caspases (caspase-1, −3, −4, −5, −6, −7, −8 and −9), or with
the specific inhibitors for caspase-8 (FAM-LETD-FMK) or
caspase-9 (FAM-LEHD-FMK), following the manufacturer’s
instructions (Immunochemistry Technologies, LLC, Bloo-
mington, MN, USA). Cells were then washed twice with
1 mL of wash buffer (included in the kit) and resuspended in
600 μL of the same solution. Each sample was divided into
two aliquots of 300 μL: one was directly analyzed by flow
cytometry or, alternatively, fixed (by adding the fixative pro-
vided with the kit) and analyzed within 24 h; the other sample,
prior to analysis, was supplemented with 1.5 μL of a ready-to-
use solution of Propidium Iodide (PI) (250 μg/mL), which
stained necrotic, dead and membrane-compromised cells, thus
enabling live and dead cells to be distinguished within
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caspase-positive or -negative subsets. Samples labeled with
FLICA and PI were directly read by flow cytometry, as the
bicolor PI protocol did not allow cell fixing.
Western Blot Analysis
Western blot was performed to evaluate PBMC levels of
Bip/GRP78, GADD153, active caspase-12 and its precursor
procaspase 12. PBMC, recovered after 48 and 72 h of
culture as described above, were washed and resuspended
in ice-cold lysis buffer containing 10 mM Hepes (pH 7.9),
10 mM KCl, 0.1 mM EDTA (pH 8.0), 0.2 mM EGTA (pH
6.0), 1 mM DTT, 1 mM phenylmethylsulfonyl fluoride,
10 μg/ml aprotinin, 10 μg/ml leupeptin, 1 mM sodium
orthovanadate and 1 mM sodium fluoride for 15 min at 4°C.
After addition of 10% Nonidet, samples were mixed and
centrifuged, thereafter supernatants were mixed with sample
buffer (2% sodium dodecyl sulphate [SDS], 7% glycerol,
0.72 M β-mercaptoethanol, 62.5 mM Tris–HCl, pH 6.8),
heated at 100°C for 5 min and then frozen at −80°C until
use. Samples were subjected to 10% polyacrylamide gel elec-
trophoresis, after which proteins were electrophoretically
transferred from the gel onto a nitrocellulose membrane in a
buffer containing 25 mM Tris, 192 mM glycine and 20%
methanol at 5.5 mA/cm2 for 30 min at room temperature.
Residual binding sites on the membrane were blocked by
incubating the membrane in blocking buffer (Tris-buffered
saline pH 7.6 with 0.1% Tween 20 and 5% non-fat dry milk)
for 1 h at room temperature under gentle agitation. After
washing in Tris-buffered saline containing 0.1% Tween 20
(TBST), the membrane was incubated at 4°C overnight with
rabbit polyclonal Abs anti-BiP/GRP78 (1 μg/ml), anti-
caspase-12 (2 μg/ml), anti-procaspase-12 (1 μg/ml) or mouse
monoclonal Abs to GADD153 (1 μg/ml) (all purchased from
Abcam, Cambridge, UK). As secondary Abs, goat anti-rabbit
IgG (Cell Signaling Technology, Beverly, MA, USA) or goat
anti-mouse IgG (Abcam), both conjugated with horseradish
peroxidase (1:10,000 in blocking buffer), were used and the
membrane was kept at room temperature for 90 min under
gentle agitation. The Ab complexes were visualized by the
ECL Plus Western Blotting Detection Reagents (Amersham
Biosciences Europe, Milan, Italy), following the manufac-
turer’s instructions, and subsequently densitometric analysis
of each band was performed bymeans of the ImageMaster 1D
Image Analysis Software (Amersham Biosciences Europe).
Values were normalized to β-actin, assessed by stripping the
membranes with the RestoreTM Stripping Buffer (Pierce,
Rockford, IL, USA) and reprobing them with rabbit polyclon-
al anti-β-actin Abs (1:1000) (Santa Cruz Biotechnology, CA,
USA).
To compare values from different gels, one lane of each gel
was loaded with a control sample. After transfer and blocking,
the membrane was cut and the control lane incubated with
rabbit polyclonal Abs against β-actin (1:2000), chosen as
house-keeping protein, before being processed together with
the remaining part of the membrane as described above.
Therefore, for each protein, values obtained from different
experimental points were normalized to the β-actin of the
control lane to offset any variations due to the different expo-
sure of single membranes.
Statistical Analysis
Statistical analysis was performed by Student t test. Statis-
tical significance was set at a value of P<0.05.
Results
Lymphocyte Spontaneous Apoptosis in Patients Chronically
Infected with HCV
The spontaneous apoptosis time course of peripheral blood
lymphocytes was evaluated in all patients with chronic
hepatitis C and compared with that exhibited by cells iso-
lated from healthy donors. On the basis of pilot experiments,
in which the proportion of apoptotic cells was measured
daily for 10 days, data obtained at day 3 (T3) and day 7
(T7) of cell culture were considered the most representative
(Figure 1). Simultaneous staining with the Annexin V-FITC/
7-AAD kit, anti-CD19-PE and anti-CD3-ECD mAbs
allowed differential analysis of B and T cell apoptosis.
Lymphocytes from HCV+patients were found to undergo
apoptosis quite rapidly, the percentage of apoptotic cells being
significantly higher in the HCV+subset with respect to healthy
controls already by 3 days of culture (mean±SD: 13.3±8.9%
and 6.6±2.3% in patients and controls, respectively, p<0.01)
(Figure 2) . Then apoptotic events increased over time in the


















Fig. 1 Time course evaluation of lymphocyte apoptosis occurring spon-
taneously in patients with chronic HCV infection and healthy
donors (n04). Data are expressed as percentage of Annexin V+7-AAD-
lymphocytes (mean±SD)
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of HCV patients, so that the extent of the apoptotic process
was comparable in patients and controls after seven days of
cell culture (11.8±8.2% versus 12.1±7.4%, respectively,
values being expressed as mean±SD) (see Figure 2).
A detailed analysis within B and T cell populations high-
lighted that the above-described trend of early apoptotic phe-
nomena seen in HCV patients was restricted to the CD3+ Tcell
subset (mean±SD of apoptotic events in patients and controls,
respectively: 9.6±6.8% and 5.0±2.9% in CD3+ cells, p<0.02;
2.4±1.9% and 1.9±1.4% in CD19+ cells) (Figure 3).
Effects of the Chimeric Virus R9-CMVon Lymphocyte
Apoptosis
Several reports have suggested that HCVmay have significant
effects on cell viability [8–13]. However, only few studies
were focused on the effects of HCV molecules on the modu-
lation of apoptotic events in the peripheral immune system.
This prompted us to evaluate whether the HVR1-derived R9
mimotope might affect peripheral lymphocyte apoptosis. To
this aim, a comparative analysis of spontaneous and R9-
CMV-mediated apoptosis was carried out in PBMC from
HCV patients and healthy donors. Cell apoptosis in the pres-
ence of the plant virus vector alone (CMV-D/S) or the syn-
thetic peptide R9 was also assessed in parallel cultures.
After 3 days, chimeric R9-CMV accelerated the apoptotic
events occurring in untreated cells, with the lymphocytes from
HCV patients being more susceptible to pro-apoptotic effects
of the chimeric virus (see Figure 4). From then on, R9-CMV-
triggered apoptotic phenomena increased in all subjects but,
similarly to what was observed in unstimulated conditions,
this effect was more pronounced in healthy controls. As a
result, a difference in terms of apoptotic events between
patients and controls was no longer observed after 7 days of
R9-CMV-stimulation (Figure 4). Finally, as shown in Fig. 4,


















Fig. 2 Lymphocyte spontaneous apoptosis in patients with chronic
HCV infection (n040) and healthy donors (n020). Each dot represents
individual donor’s data expressed as percentage of Annexin V+7-AAD-
lymphocytes at day 3 (T3) and day 7 (T7) of cell culture. Mean values
are indicated by horizontal bars. Significance of HCV versus HD:
















Fig. 3 Spontaneous apoptosis in T and B lymphocytes from patients
with chronic HCV infection (n030) and healthy donors (n015). Dots
represent individual donor’s data expressed as percentage of Annexin
V+7-AAD- CD3+ or CD19+ lymphocytes after 3 days of cell culture.
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Fig. 4 R9-CMV-induced apoptotic effects on lymphocytes from
patients with chronic HCV infection (n040) and healthy donors (n020).
Data are expressed as percentage of apoptotic lymphocytes (mean±SD) at
day 3 (T3) and day 7 (T7) of cell culture in the absence of stimuli (NS) or
after stimulation with R9-CMV, R9 peptide or CMV-D/S. Significance of
HCV versus HD: *p<0.01; §p<0.001; significance of R9-CMV versus
homologous NS cells: @p<0.005; &p<0.001
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had negligible effects on spontaneous cell apoptosis in both
patients and controls.
Analysis of lymphocyte subsets showed that although
R9-CMV-mediated apoptosis occurred in both T and B cells,
B lymphocytes, and especially those from HCV patients,
were particularly sensitive to the pro-apoptotic effects of the
chimeric virus (Figure 5).
Effects of R9-CMVon Intracellular Caspase Activation
in PBMC from HCV+Patients
The central component of the apoptotic process is a cascade
of proteolytic enzymes known as caspases. To determine
whether cell apoptosis induced by R9-CMV was associated
with caspase activation, PBMC from HCV+patients were
incubated with fluorochrome-labeled inhibitors of caspases
(FLICA). By binding covalently to active caspases, FLICA
label cells that have undergone apoptosis through caspase
activation. Preliminary experiments showed that by using
FAM-VAD-FMK, a generic probe for the detection of most
caspases (caspase-1, −3, −4, −5, −6, −7, −8 and −9), a
higher percentage of cells showing active caspases was
found as a result of R9-CMV cell challenge as compared to
unstimulated cells at both T3 and T7 (data not shown). By
contrast, no significant differences in terms of FAM-VAD-
FMK staining were detected between unstimulated cells and
cells incubated with the synthetic R9-mimotope or the vector
CMV-D/S throughout the incubation period (data not shown).
To assess whether R9-CMV-induced apoptosis occurred
via a death receptor or a mitochondrial pathway, cells from
HCV+patients were stained with FAM-LETD-FMK and
FAM-LEHD-FMK, that primarily detect active caspases-
8 and −9, respectively. We found that both caspases were
significantly activated as a result of R9-CMV cell challenge,
with caspase-8 activation being more impressive than caspase-
9 activation at both T3 (caspase positive lymphocytes in unsti-
mulated versus R9-CMV stimulated cells: 2.4±1.2% and 4.3±
1.4% for caspase 8, p<0.002; 4.3±1.3 and 6.0±1.5 for caspase
9, p<0.01) and T7 culture time (unstimulated versus R9-CMV
stimulated cells: 6.6±5.7% and 21.2±9.4% for caspase 8, p<
0.001; 11.8±6.9 and 24.2±9.9 for caspase 9, p<0.002)
(Figure 6).
To further analyze the relationship between caspase activa-
tion and R9-CMV-triggered apoptosis, we tested the ability of
specific purified inhibitors for caspases 8 and 9 to block both
spontaneous and R9-CMV-induced apoptosis. As shown in
Figure 6, spontaneous apoptosis was found to be significantly
reduced only in the presence of the caspase-8 inhibitor Z-
IETD-FMK, whereas R9-CMV-dependent apoptosis was
inhibited in the presence of either the caspase-8- or the






















Fig. 5 Effects of R9-CMV on T and B cell apoptosis in patients with
chronic HCV infection (n030) and healthy donors (n015). Data are
expressed as percentage of apoptotic CD3+ or CD19+ lymphocytes
(mean±SD) after 3 days of cell culture in the absence or presence of
R9-CMV as stimulant. Significance of HCV versus HD: **p<0.02;





































Fig. 6 Effects of R9-CMVon caspase activation in lymphocytes from
patients with chronic HCV infection (n012). Each dot represents
individual donor’s data expressed as percentage of caspase-8 or −9
positive lymphocytes at day 3 (T3) and day 7 (T7) of cell culture in the
absence of stimuli (NS) or after stimulation with R9-CMV. Mean
values are indicated by horizontal bars. Significance of R9-CMV
versus homologous NS cells: ***p<0.01; øp<0.002; &p<0.001
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Finally, following R9-CMV stimulation, no significant
modifications of active caspase-8 levels were detected as a
result of selective caspase-9 inhibition, nor were differences
in the activation of caspase-9 observed following selective
inhibition of caspase-8 (data not shown).
Effects of Chimeric R9-CMVon ER-stress and Caspase-12
Signaling in PBMC from HCV+Patients
There is increasing evidence that the endoplasmic reticulum
might be implicated in the apoptotic execution. ER-associated
pro-apoptotic molecules include caspase-12, Bap31 and
GADD153 [25–28], whereas the chaperone protein BiP/
GRP78 is an anti-apoptotic molecule that is strongly induced
in response to ER-stress [26, 28].
Considering that the ER is the main cellular compartment
where the vital cycle of HCV takes place, we investigated its
role in R9-CMV-induced apoptotic phenomena. To this aim,
PBMC from HCV+patients were stimulated for 48 and 72 h
with the chimeric virus and then the levels of BiP/GRP78 and
GADD153 were assayed. Cells triggered with TG, which
induces ER-stress through Ca++-adenosine triphosphatase in-
hibition [28], were considered as positive controls. Results
demonstrated significant induction of both BiP/GRP78 and
GADD153 as a result of R9-CMV cell stimulation (Figure 8).
The effects of R9-CMV and TG on cellular levels of the
enzyme inactive precursor procaspase-12, as well as of the
active form of caspase-12, were also assessed. Interestingly,
both stimulants gave rise to an increase in active caspase-12
that was paralleled by a progressive consumption of its pre-
cursor (Figure 8). All protein changes paralleled apoptotic
events at 48 h (data not illustrated) and 72 h (Figure 8), as
assessed by Annexin V staining of cells maintained under the
same experimental conditions.
Discussion
The role of apoptosis in HCV-related disease is still far from
clear. Several aspects need to be better clarified, including the
kinetics and extent of apoptotic processes, the expression of
pro-apoptotic mediators during acute and chronic phases of
infection, as well as their potential links to virus persistence.
In the current study, the early spontaneous apoptotic death
exhibited in vitro by T cells from HCV+patients is likely a
direct effect of the virus, exerted to escape immunological
defenses or enhance its pathogenicity. An increased apoptotic
T cell death has previously been described in chronic HCV-
infected patients [29, 30], but only when in vitro “activated”
peripheral T cells or T lymphocytes co-cultured with mitogen-
activated monocytes were analyzed. The time course ap-
proach to the evaluation of T cell spontaneous apoptosis
adopted in this study has disclosed this HCV pro-apoptotic
effect also on resting T lymphocytes.
The chimeric plant virus R9-CMV has already been dem-
onstrated to up-regulate HCV-specific immune responses [6,
7]. On these bases, it was of particular interest to use this
chimeric system to study possible HCV HVR1 modulating
effects on peripheral lymphocyte apoptosis. We found that,
unlike the purified form of the R9 peptide, R9-CMVexhibited
an early pro-apoptotic action in PBMC cultures from both
patients and controls. Such an effect is clearly ascribable to the
R9 residue expressed by the chimeric virus, as the pseudor-
ecombinant CMV-D/S produced only negligible variations of
lymphocyte apoptosis. The R9-CMV-mediated apoptotic ef-
fect observed in cells from healthy subjects is in line with
evidence relating hepatocyte apoptosis with a cytopathic ef-
fect of HCV proteins [31, 32]. This further suggests that the
glycoprotein E2, from which the synthetic R9 mimotope is


















Fig. 7 Effects of caspase inhibitors on spontaneous and R9-CMV-
induced apoptosis in lymphocytes of patients with chronic HCV infec-
tion. PBMC from HCV+patients were incubated without (None) or
with purified caspase-8 (Z-IETD-FMK) or caspase-9 (Z-LEHD-FMK)
inhibitors. Data are expressed as percentage of Annexin V+7-AAD-
lymphocytes after 3 days of cell culture in the absence (NS) or pres-
ence of R9-CMV as stimulant, and are representative of 7 experiments
with similar results
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induced by the virus. On the other hand, the possibility that
E2-induced lymphocyte apoptosis contributes to allow HCV
to escape the host immune surveillance cannot be ruled out. In
this regard, it should be stressed that R9-CMV-mediated
effects, even if evident in both patients and controls, were
more pronounced in HCV-infected subjects, thus indicating
the ability of R9 mimotope, repeatedly expressed on this
peculiar vector, to stimulate a memory immune response in
the infected host.
In the last few years, it has been widely demonstrated that
the apoptotic process involves a family of conserved intra-
cellular proteases, called caspases, present in the cytosol of
most cells as inactive proenzymes. During the execution
phase, the concerted action of molecular and biochemical
steps leads to the activation of common effectors or down-
stream caspases, which dismantle the cell by sequential
cleavage of nuclear and cytoplasmic substrates [33, 34].
Two major pathways are known to activate these effector
caspases: one involves death factors and death receptors (the
“extrinsic” pathway), recruiting an intracellular death com-
plex that activates a class of apical caspases, most notably
caspase-8; the “intrinsic” pathway is related to mitochondrial
dysfunction which, in turn, activates a different initiator cas-
pase, caspase-9, also localized in the cytoplasm. Thereafter,
the pathways converge in the activation of downstream cas-
pases, such as caspase-3, −6 or −7 [33, 34].
By using a generic probe for the detection of most intra-
cellular active caspases, we have shown that lymphocyte
stimulation with the chimeric plant virus R9-CMV, but not
with the synthetic R9 mimotope or with the empty vector
CMV-D/S, was associated with caspase activation. More-
over, although both active caspase 8 and 9 were detected as
a result of incubation with the chimeric virus, a predominant
role of caspase-8might be hypothesized, based on the evidence
of a greater increase in the levels of active caspase-8 rather than
caspase-9, in stimulated versus unstimulated cells. These
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results, together with data from our previous reports depicting
the R9-CMV property to induce a TCR-mediated T cell acti-
vation and to stimulate a dominant Th-1-driven immune re-
sponse [6, 7], led us to hypothesize a novel mechanism
underlying the complex interaction between HCV and the
infected host. Activation-induced cell death (AICD) is
regarded as a major homeostatic mechanism in the immune
system. This particular apoptosis pathway is thought to result
from repeated Tcell stimulation by persistent antigens, with the
consequent engagement of death receptors and activation of
caspase-8 [35, 36]. While interleukin-2 has been shown to
sensitize T cells to AICD by enhancing Fas ligand expression,
interferon-γ seems to act through the induction of caspase-
8 expression downstream of the Fas death receptor [37]. These
data are consistent with the evidence that R9-CMV-dependent
apoptotic effects occur in the absence of a significant increase
in cell surface Fas expression and that neutralizing anti-Fas
ligand antibodies fail to rescue R9-CMV-stimulated lympho-
cytes from apoptosis (Piazzolla G, Tortorella C, unpublished
observations). Furthermore, they are particularly intriguing in
the light of previous reports showing that caspase-8 activity is
required for the establishment of T cell memory during viral
and protozoan infections [38, 39] and that an immunodeficien-
cy syndrome with defective lymphocyte activation occurs in
humans as a result of a caspase-8 mutation abrogating enzy-
matic activity [40]. It might be argued that the R9 mimotope
has the intrinsic property of regulating both the elimination of
repeatedly activated T cells and the generation of long-lived
memory CD8+ Tcells through caspase-8 activation. This latter
feature, together with the capacity of R9-CMV to enhance Ag-
specific CD8+ immune responses [6], opens up new prospects
in the sense that they may offer both a novel vaccination
strategy against HCVand a tool for boosting the effectiveness
of such vaccines.
Caspase-9 activation, also triggered byR9-CMV, is another
interesting aspect. By supplementing cell cultures with spe-
cific inhibitors for caspase-8 or caspase-9, we found that
spontaneous apoptosis was inhibited only in the presence of
the caspase-8 inhibitor Z-IETD-FMK. Conversely, both Z-
IETD-FMK and Z-LEHD-FMK, the specific inhibitor of
caspase-9, were found to be efficacious in decreasing R9-
CMV-dependent apoptosis. In our experimental conditions, a
crosstalk between the two main apoptotic pathways as a result
of R9-CMV cell stimulation seems unlikely as we did not
detect a significant reduction in caspase-9 activation following
specific inhibition of caspase-8, nor a decrease in levels of
active caspase-8 as a result of caspase-9 inhibition. The con-
nection between R9-CMV and caspase-9 activation might
rather be provided by a third subcellular compartment impli-
cated in apoptotic execution, namely the endoplasmic reticu-
lum. Alterations in calcium homeostasis are known to cause a
calcium-dependent disruption of ER function, referred to as
“ER-stress”, an event that may lead to apoptosis via caspase-9
and caspase-12 activation [41, 42]. In this regard, it has been
reported that HCV E2-mediated cross-linking of CD81 lowers
the TCR-mediated T cell activation threshold of naive and
antigen-experienced T cell subsets, thereafter inducing cell
calcium influx [43]. Likewise, it is plausible that the R9
mimotope expressed on the surface of the chimeric CMV in
an ordered array of hundreds of molecules empowers the
chimeric virus to cross-link lymphocyte CD81 and to induce
cell calcium influx. The consequent elevation of intracellular
calcium levels might thus trigger “ER-stress” ultimately lead-
ing to apoptosis. Our evidence that B lymphocytes, which are
known to express high levels of CD81 on their surface, were
particularly sensitive to R9-CMV-mediated apoptosis is
consistent with this view. The role of ER-stress in our
model was then confirmed by pilot experiments showing
a significant induction of the ER-associated pro-
apoptotic molecule GADD153, as well as of the ER-
chaperon Bip/GRP78 protein, following R9-CMV lym-
phocyte treatment. In particular, Bip/GRP78 is a key
mediator of the unfolded protein response (UPR), the
adaptive program activated by cells to alleviate ER-
stress, so the levels of this protein serve as an indicator
of ER-stress [28, 44]. Interestingly, Bip/GRP78 levels
measured in lymphocytes fromHCV+patients following stim-
ulation with the chimeric plant virus were similar to those
assessed in cell cultures treated with TG, which is known to
induce ER-stress through changes in intracellular calcium
concentrations [28]. In keeping with these findings, a signif-
icant increase in active caspase-12 levels and a parallel con-
sumption of its precursor procaspase-12 were detected both in
R9-CMV- and TG-stimulated cell cultures under the same
experimental conditions, this suggesting the possible role of
caspase-12 as an effector caspase of the apoptotic pathway
triggered by R9-CMV.
In conclusion, our results support the feasibility of pro-
ducing a plant-derived Ag-presenting system to strengthen
host defences against persistent pathogens. Particularly in-
teresting and worthy of further investigation is the R9-CMV
ability to stimulate a TCR-mediated T cell activation and, at
the same time, to enhance a caspase-8-dependent immuno-
logical memory towards HCV. The role of R9-CMV in the
modulation of ER-mediated cell apoptosis, whose impor-
tance in HCV infection is still largely unexplored, opens up
new prospects for clarifying mechanisms involved in the
pathogenesis of HCV-induced tissue damage and/or in the
persistence of the virus.
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